Matthew Wiley
2022
In 2022, Matthew Wiley earned a total compensation of $1.9M as SVP and Chief Commercial Officer at BioXcel Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $210,000 |
|---|---|
| Option Awards | $1,307,572 |
| Salary | $402,500 |
| Other | $7,625 |
| Total | $1,927,697 |
Wiley received $1.3M in option awards, accounting for 68% of the total pay in 2022.
Wiley also received $210K in non-equity incentive plan, $402.5K in salary and $7.6K in other compensation.
Rankings
In 2022, Matthew Wiley's compensation ranked 1,815th out of 5,760 executives tracked by ExecPay. In other words, Wiley earned more than 68.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,815 out of 5,760 | 69th |
Division Manufacturing | 952 out of 3,136 | 70th |
Major group Chemicals And Allied Products | 386 out of 1,422 | 73rd |
Industry group Drugs | 353 out of 1,323 | 73rd |
Industry Pharmaceutical Preparations | 253 out of 969 | 74th |
Source: SEC filing on May 17, 2023.
Wiley's colleagues
We found two more compensation records of executives who worked with Matthew Wiley at BioXcel Therapeutics in 2022.